Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept

ABSTRACT: The American Diabetes Association guidelines for the management of type 2 diabetes mellitus recommends treating patients with atherosclerotic cardiovascular diseases, heart failure or diabetic kidney disease with sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Varadhan, Lakshminarayanan, Saravanan, Ponnusamy, Ali, Sarah N., Hanif, Wasim, Patel, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Practical Application
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809249/
https://www.ncbi.nlm.nih.gov/pubmed/35107773
http://dx.doi.org/10.1007/s40261-021-01105-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809249/
https://www.ncbi.nlm.nih.gov/pubmed/35107773
http://dx.doi.org/10.1007/s40261-021-01105-7

Ejemplares similares